Our findings indicate that chemokine signaling pathway plays a fundamental role in highly malignant IDH wild-type astrocytomas, and it can be considered as a potential therapeutic target for astrocytomas. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).